Posted in | News

IIG to Release New High-Temperature Insulation Product for Industrial Applications

Industrial Insulation Group (IIG), the leading manufacturer of insulation for industrial, commercial and fireproofing applications and a wholly owned subsidiary of Johns Manville (JM), announced today that they will be releasing InsulThin™ HT, a new product in its industrial insulation materials portfolio.

InsulThin HT is a flexible, hydrophobic, microporous, fumed silica, blanket insulation. This thin, high-temperature insulation material has an extremely low k-factor, reducing the space required for effectively insulating pipe and equipment. InsulThin HT can easily wrap both large and small diameter piping without sacrificing its exceptional insulating properties, superior corrosion performance, and high standard for ease-of-installation.

“InsulThin HT is a unique offering to the market segment that desires superior thermal performance and resistance to corrosion under insulation (CUI) in areas that have limited space,” said Fred Stephan, senior vice president and general manager of JM’s Insulation Systems business. He explained that Johns Manville first developed this technology in 1990. Since then, the market needs have evolved, creating an excellent opportunity for IIG to bring InsulThin HT to the industrial market. Stephan observed that IIG’s existing products continue to be the trusted solutions for the industry, with Thermo-12® Gold calcium silicate insulation providing the added benefit of resistance to mechanical abuse with equal or improved resistance to CUI, a unique characteristic resulting from the XOX additives in the product’s formulation.

“In launching InsulThin HT,” Stephan added, “our strategy is to continue to expand our portfolio of industrial insulation products to provide solutions for the wide array of industry requirements. We are also building a team of trusted consultants to help customers choose the best solution to meet the unique demands of each project and application.”

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.